Literature DB >> 10903482

Inhibition of lipoprotein lipase activity by sphingomyelin: role of membrane surface structure.

H Saito1, I Arimoto, M Tanaka, T Sasaki, T Tanimoto, S Okada, T Handa.   

Abstract

We have recently shown that sphingomyelin (SM) strongly inhibits lipoprotein lipase (LPL)-mediated lipolysis in monolayers and emulsion particles. To further evaluate how SM modulates LPL activity on the emulsion surface, the relationship between membrane surface structure and LPL activity was investigated. We measured fluorescence anisotropy of 1-palmitoyl-2-[3-(diphenylhexatrienyl)propionyl]-sn-3-phosphati dylcho line, probing surface acyl chain fluidity, and fluorescence lifetime of N-(5-dimethylaminonaphthalene-1-sulfonyl)dipalmitoylphosphatidylethan olamine in H(2)O and D(2)O buffer, assessing the degree of hydration in the head group region. The results revealed that incorporation of egg SM into triolein-egg phosphatidylcholine emulsions markedly increased acyl chain order and decreased head group hydration of the surface monolayers. In contrast, cholesterol was shown to increase head group hydration despite a strong increase in acyl chain order. The close correlation between the apparent K(m) values of LPL and the degree of head group hydration indicated that LPL interacts with the head group region rather than with the hydrophobic interior of the surface monolayers. However, apparent V(max) did not show a simple correlation with any surface structure, and the finding in which SM had no effect on apparent V(max) of medium-chain triglyceride emulsions suggested that the hydrophobic interaction between acyl chains of SM and triglyceride at the emulsion surface is important for determining the apparent V(max). These results showed conclusively that SM inhibits LPL activity mainly by changing the emulsion surface structure and not by a specific interaction between SM and LPL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903482     DOI: 10.1016/s1388-1981(00)00071-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Unraveling the complexities of the HDL lipidome.

Authors:  Anatol Kontush; Marie Lhomme; M John Chapman
Journal:  J Lipid Res       Date:  2013-03-30       Impact factor: 5.922

2.  Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction.

Authors:  Su-Yeon Lee; Jung Ran Kim; Yunying Hu; Raffay Khan; Su-Jung Kim; Kalyani G Bharadwaj; Mercy M Davidson; Cheol-Soo Choi; Kyong-Oh Shin; Yong-Moon Lee; Woo-Jin Park; In-Sun Park; Xian-Cheng Jiang; Ira J Goldberg; Tae-Sik Park
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

3.  Properties of palmitoyl phosphatidylcholine, sphingomyelin, and dihydrosphingomyelin bilayer membranes as reported by different fluorescent reporter molecules.

Authors:  Thomas Nyholm; Matts Nylund; Annu Söderholm; J Peter Slotte
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

4.  Liver-specific deficiency of serine palmitoyltransferase subunit 2 decreases plasma sphingomyelin and increases apolipoprotein E levels.

Authors:  Zhiqiang Li; Yan Li; Mahua Chakraborty; Yifan Fan; Hai H Bui; David A Peake; Ming-Shang Kuo; Xiao Xiao; Guoqing Cao; Xian-Cheng Jiang
Journal:  J Biol Chem       Date:  2009-08-01       Impact factor: 5.157

5.  Vitamin A and D Absorption in Adults with Metabolic Syndrome versus Healthy Controls: A Pilot Study Utilizing Targeted and Untargeted LC-MS Lipidomics.

Authors:  Haley Chatelaine; Priyankar Dey; Xiaokui Mo; Eunice Mah; Richard S Bruno; Rachel E Kopec
Journal:  Mol Nutr Food Res       Date:  2020-12-07       Impact factor: 5.914

6.  Loss of G protein pathway suppressor 2 in human adipocytes triggers lipid remodeling by upregulating ATP binding cassette subfamily G member 1.

Authors:  Serena Barilla; Ning Liang; Enrichetta Mileti; Raphaëlle Ballaire; Marie Lhomme; Maharajah Ponnaiah; Sophie Lemoine; Antoine Soprani; Jean-Francois Gautier; Ez-Zoubir Amri; Wilfried Le Goff; Nicolas Venteclef; Eckardt Treuter
Journal:  Mol Metab       Date:  2020-08-13       Impact factor: 7.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.